COVID-19 assay kit

immunityfor neutralizing antibodySARS-COV-2

SARS-CoV-2 Neutralizing Antibody Assay Kit (Fluorescence Immunochromatography) is used to quantitatively detect the 2019-nCoV neutralization antibodies in clinical samples (serum asmal/whole blood). What are COVID-19 neutralizing antibody rapid tests? ● COVID-19 SARS-CoV-2 Neutralizing Antibody Assay Kit is a point of care test for use in multiple testing locations and has high sensitivity and specificity. Meaning it has the potential to play a vital supporting role out of the pandemic. ● Screen for an immune response following COVID-19 infection or vaccination ● A testing solution for multiple scenarios: workplace testing, border control or vaccine rollout What are neutralizing antibodies? Following infection, the body produces antibodies targeting specific parts of the SARS-CoV-2 (COVID-19) virus with the Nucleocapsid protein and the Spike protein being of importance in the context of antibody tests. The coronavirus nucleocapsid protein is a multi-functional protein1 and the spike protein is integral in penetrating human cells and initiating infection. Neutralizing Antibody Rapid Test Intended Use Neutralizing Antibody Rapid Test Intended Use spike (S), envelope (E), membrane (M), and nucleocapsid (N). The S-protein contains a receptor binding domain (RBD), which can recognize the cell surface receptor, angioten- sin-converting enzyme-2 (ACE2). In a recent study, neutralizing antibody (NAb) can block the interaction between the receptor-binding domain (RBD) of the novel coronavirus spike protein with the ACE2 cell surface receptor. The level of NAb, therefore, can be used to analyze a patient's immunity against future SARS-CoV-2 infection.